Skip to main content
. 2012 Nov 1;1:8. doi: 10.1186/2046-2395-1-8

Table 2.

Main modifications of lymphocytes subpopulations between Alzheimer’s disease patients and age-matched controls

Phenotype Lymphocyte subpopulation Changesin Alzheimer disease Reference
CD19+
Total B cells
Decrease
[82]
(percentage)
 
 
[83]
 
 
 
[63]
CD19+
Total B cells
Decrease
[82]
(absolute number)
 
 
[63]
CD3+
Total T cells
No change
[63]
(percentage)
 
Decrease
[81]
 
 
 
[83]
 
 
 
 
CD3+CD8+(percentage)
Cytotoxic T lymphocytes
No change
[63]
 
 
 
[83]
 
 
Decrease
[81]
CD3+CD4+
T-helper cells
No change
[63]
(percentage)
 
 
[83]
 
 
Increase
[81]
CD3+CD4+CD45RA+CCR7+
Naïve CD4+ T
Decrease
[79]
(percentage)
cells
 
 
CD3+CD4+CD28+CD27+CD45RA+CD45RO-
Naïve CD4+ T
Decrease
[75]
(percentage)
cells
 
 
CD3+CD4+CD45RA-CCR7-
Effector memory
Increase
[79]
(percentage)
CD4+ T cells
 
 
CD3+CD4+CD45RA+CCR7-(percentage)
Terminal effector memory RA cells
Increase
[79]
 
 
 
 
CD3+CD4+CD28-CD27-CD45RA+CD45RO+
Late differentiated
Increase
[75]
(percentage)
CD4+ T cells
 
 
CD3+CD4+CD25high
Activated CD4+ T
Decrease
[79]
(percentage)
cells
 
 
CD3+CD4+CD25+FoxP3+CD127low(percentage)
Regulatory T cells
No change
[75]
CD3+CD4+KLRG-1+(percentage) Senescent CD4+ T cells Increase [75]